abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to pharmacology and medicine. Substance of the invention consists that an immunocorrective drug exhibiting an intense specific antiviral activity for treating diseases of viral aetiology contains human recombinant interferon alpha and/or beta, and/or gamma, an antioxidant complex of tocopherol acetate or its derivative, including water-soluble ones, and ascorbic acid salts, calcium pantothenate, antiviral ingredients, as well as pharmaceutical aids and excipients in certain ratios in 1 g of the drug. As antiviral ingredients, the drug contains arbidol and its derivatives, remantadin, oseltamivir, ribavirin, inosine pranobex (isoprinosine), glycyrrhizic acid and its derivatives, nucleosides of a group - famvir, valacyclovir, ganciclovir, valganciclovir, foscarnet, cidofovir, lobucavir, sorivudine, brivudine, antiretroviral - lamivudine, zidovudine, lopinavir, stavudine. The agent is presented in rectal and vaginal suppositories, gel, ointment, liquid. n EFFECT: invention provides higher therapeutic effect and high bioavailability for treating the diseases of viral aetiology. n 5 cl, 17 ex |